Assenagon Asset Management S.A. Sells 66,196 Shares of Addus HomeCare Corporation (NASDAQ:ADUS)

Assenagon Asset Management S.A. decreased its holdings in Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) by 91.6% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,087 shares of the company's stock after selling 66,196 shares during the period. Assenagon Asset Management S.A.'s holdings in Addus HomeCare were worth $602,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of the business. Summit Place Financial Advisors LLC increased its holdings in shares of Addus HomeCare by 0.9% in the 4th quarter. Summit Place Financial Advisors LLC now owns 9,410 shares of the company's stock worth $1,180,000 after purchasing an additional 80 shares in the last quarter. Alliancebernstein L.P. increased its holdings in shares of Addus HomeCare by 0.5% in the 4th quarter. Alliancebernstein L.P. now owns 19,661 shares of the company's stock worth $2,465,000 after purchasing an additional 91 shares in the last quarter. Natixis increased its holdings in shares of Addus HomeCare by 111.9% in the 4th quarter. Natixis now owns 250 shares of the company's stock worth $31,000 after purchasing an additional 132 shares in the last quarter. Heritage Family Offices LLP increased its holdings in shares of Addus HomeCare by 6.3% in the 1st quarter. Heritage Family Offices LLP now owns 2,417 shares of the company's stock worth $239,000 after purchasing an additional 143 shares in the last quarter. Finally, Parkside Financial Bank & Trust increased its holdings in shares of Addus HomeCare by 38.6% in the 4th quarter. Parkside Financial Bank & Trust now owns 531 shares of the company's stock worth $67,000 after purchasing an additional 148 shares in the last quarter. Institutional investors own 95.35% of the company's stock.

Insider Activity

In other news, EVP Michael D. Wattenbarger sold 2,045 shares of Addus HomeCare stock in a transaction dated Tuesday, May 27th. The stock was sold at an average price of $115.00, for a total value of $235,175.00. Following the sale, the executive vice president now directly owns 7,796 shares of the company's stock, valued at approximately $896,540. The trade was a 20.78% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 4.60% of the company's stock.

Addus HomeCare Price Performance

NASDAQ ADUS opened at $115.16 on Thursday. The company has a market capitalization of $2.12 billion, a PE ratio of 26.00, a price-to-earnings-growth ratio of 1.61 and a beta of 0.81. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.74 and a current ratio of 1.74. The business's fifty day moving average is $108.39 and its 200 day moving average is $112.09. Addus HomeCare Corporation has a fifty-two week low of $88.96 and a fifty-two week high of $136.72.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its earnings results on Monday, May 5th. The company reported $1.42 earnings per share for the quarter, beating the consensus estimate of $1.33 by $0.09. Addus HomeCare had a return on equity of 9.23% and a net margin of 6.52%. The company had revenue of $337.71 million for the quarter, compared to the consensus estimate of $341.66 million. During the same period in the previous year, the business earned $1.21 earnings per share. Addus HomeCare's quarterly revenue was up 20.3% compared to the same quarter last year. Sell-side analysts predict that Addus HomeCare Corporation will post 4.59 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of analysts have commented on the company. Wall Street Zen lowered Addus HomeCare from a "buy" rating to a "hold" rating in a report on Wednesday, February 26th. Stephens restated an "overweight" rating and issued a $142.00 price target on shares of Addus HomeCare in a research note on Wednesday, March 12th. JMP Securities restated a "market outperform" rating and issued a $150.00 price target on shares of Addus HomeCare in a research note on Tuesday, April 22nd. Finally, Macquarie restated an "outperform" rating and issued a $133.00 price target on shares of Addus HomeCare in a research note on Tuesday, June 10th. One investment analyst has rated the stock with a hold rating, six have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Buy" and a consensus target price of $142.57.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Corporation (NASDAQ:ADUS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.